Three-Drug Regimen Treats Cystic Fibrosis in Younger Children

IV Oral Antibiotics Comparable for Treating P. aeruginosa in CF

Elexacaftor-Tezacaftor-Ivacaftor Efficacious for Cystic Fibrosis

For patients with cystic fibrosis with Phe508del-minimal function genotypes, elexacaftor-tezacaftor-ivacaftor, which was recently approved by the U.S. Food and Drug Administration, is efficacious, according to a study published online Oct. 31 in the New England Journal of Medicine to coincide with the annual North American Cystic Fibrosis Conference, held from Oct. 31 to Nov. 2 in Nashville, Tennessee.